# FDA Inspection 1293416 - Yashvant G. Khaire - November 13, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/yashvant-g-khaire/ffa17592-db36-487a-873d-145d68125bb9/
Source feed: FDA_Inspections

> FDA Inspection 1293416 for Yashvant G. Khaire on November 13, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1293416
- Company Name: Yashvant G. Khaire
- Inspection Date: 2025-11-13
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1293416 - 2025-11-13](https://www.globalkeysolutions.net/api/records/fda_inspections/yashvant-g-khaire/18bcdd89-aede-488a-93ed-639a2622ac5a/)
- [FDA Inspection 1206830 - 2023-06-02](https://www.globalkeysolutions.net/api/records/fda_inspections/yashvant-g-khaire/dd485280-af37-45ab-ad3b-90966cf160c6/)

Company: https://www.globalkeysolutions.net/companies/yashvant-g-khaire/2147f2dd-46d8-43f4-b61b-ce314aab58b3

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c